Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI model turns POCUS images into accurate structural heart evaluations
Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.
FAPI PET shows promise to make a big impact in cardiovascular imaging
More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
Overview of the new GE HealthCare photon-counting scanner technology
Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's FDA 510(k)-pending photon-counting CT scanner.
Exploring major trends as IVL keeps evolving
Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.
Medtronic’s newest all-in-one PFA catheter gains critical approval
The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind.

AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.

AI model turns POCUS images into accurate structural heart evaluations

Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.

SNMMI Image of the Year 68Ga-FAPI-46 PET/CT heart attack acute myocardial infarction

FAPI PET shows promise to make a big impact in cardiovascular imaging

More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.

Video interview: GE Healthcare showcased its new FDA 510(k)-pending Photonova Spectra photon-counting computed tomography (CT) scanner for the first time at the 2025 Radiological Society of North America (RSNA) meeting, which will likely become the second vendor to offer a workhorse photon-counting system. Tim Szczykutowicz, PhD, associate professor of radiology and director of clinical operations for CT protocol at the University of Wisconsin–Madison, has worked on the system for several years. #RSNA

Overview of the new GE HealthCare photon-counting scanner technology

Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's FDA 510(k)-pending photon-counting CT scanner.

Advances in calcified coronary plaque modification are increasingly centered on intravascular lithotripsy (IVL) because the technology reduces complications such as vessel trauma and perforation associated with traditional high-pressure balloons or atherectomy techniques. Cardiovascular Business spoke with Samin K. Sharma, MD, director of the Mount Sinai Fuster Heart Hospital Cardiovascular Clinical Institute, recently about the advances in IVL. #IVL #TCT

Exploring major trends as IVL keeps evolving

Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.

Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,

Medtronic’s newest all-in-one PFA catheter gains critical approval

The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind.

The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.

IVL competition heats up as Boston Scientific enters US market

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

Abbott’s medtech sales climbed in Q4 thanks to strength of heart devices

Abbott pointed to double-digit growth for its Navitor TAVR valve as well as big gains for the TriClip and MitraClip devices. The company also shared positive sales figures for its EP, heart failure and rhythm management portfolios.

Ryan Madder, MD, Program Director, Interventional Cardiology Fellowship, William Beaumont University Hospital, Corewell Health East, and Michael Abiragi, MD, cardiology fellow, Frederik Meijer Heart and Vascular Institute, Corewell Health West in Grand Rapids, explain a study showing a small number of high dose cases contribute the majority of staff dose, especially STEMI.

STEMI cases bring high doses of radiation to the cath lab

“We're so focused on quickly taking care of the patient ... we may be forgetting about radiation safety,” one researcher explained.